Type 1 Diabetes: Clinical Trials

8 trials for Type 1 Diabetes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 terminated. 8 Phase 2, 4 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Terminated 8
Phase 14Terminated 4
Phase 31Terminated 1

Follow Type 1 Diabetes: new trials by email Literature Review of Type 1 Diabetes trials Research Report on Type 1 Diabetes

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Premixed Glucagon/Insulin Solution for Faster Insulin Absorption in Type 1 Diabetes
Lyumjev 100 UNT/ML Injectable Solution, Premixed Lyumjev - Type 1 Diabetes
Phase 1 / Phase 2TerminatedSt. Olavs Hospital92025-04-012026-10-19
Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1
Glucagon - Type 1 Diabetes
Phase 2TerminatedSt. Olavs Hospital92023-12-222025-06-13
Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes.
Ladarixin, Placebo - Type 1 Diabetes
Phase 2TerminatedDompé Farmaceutici S.p.A32022-09-142025-02-03
Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes
Insulin - Type 1 Diabetes, Hyperglycemia, Postprandial
Phase 1 / Phase 2TerminatedWashington University School of Medicine12020-02-132022-10-07
A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus
VC-01 Combination Product - Type 1 Diabetes
Phase 1 / Phase 2TerminatedViaCyte312019-06-252023-10-18
Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia
intra-nasal naloxone, Intra-nasal saline - Hypoglycemia Unawareness, Type 1 Diabetes
Phase 1 / Phase 2TerminatedUniversity of Minnesota112016-06-012023-03-27
Continuous Subcutaneous Hydrocortisone Infusion In Addison's Disease and Type 1 Diabetes
Cortef, Solu-cortef - Addison Disease, Type 1 Diabetes
Phase 2TerminatedHaukeland University Hospital42013-04-242024-03-01
Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes
Closed loop, Home glucose monitoring, Insulin pump - Type 1 Diabetes
Phase 2 / Phase 3TerminatedJaeb Center for Health Research712010-09-012016-12-30

Narrower conditions

Diabetes Mellitus, Type 1 (8)  ·  Addison Disease (1)  ·  Hyperglycemia (1)  ·  Hypoglycemia (1)

Broader conditions

Autoimmune Diseases (8)  ·  Diabetes Mellitus (8)  ·  Endocrine System Diseases (8)  ·  Glucose Metabolism Disorders (8)  ·  Immune System Diseases (8)  ·  Metabolic Diseases (8)  ·  Nutritional and Metabolic Diseases (8)  ·  Adrenal Gland Diseases (1)  ·  Adrenal Insufficiency (1)

Interventions

2'-((4'-trifluoromethanesulfonyloxy)phenyl)-N-methanesulfonylpropionamide (1)  ·  Blood Glucose Self-Monitoring (1)  ·  Glucagon (1)  ·  Hydrocortisone (1)  ·  Insulin (1)  ·  Insulin Infusion Systems (1)  ·  Naloxone (1)  ·  hydrocortisone hemisuccinate (1)

Sponsors

St. Olavs Hospital (2)  ·  DompĂ© Farmaceutici S.p.A (1)  ·  Haukeland University Hospital (1)  ·  Jaeb Center for Health Research (1)  ·  University of Minnesota (1)  ·  ViaCyte (1)  ·  Washington University School of Medicine (1)

Countries

United States (4)  ·  Norway (3)  ·  Italy (1)

Top investigators

Amir Moheet, MD (1)  ·  Janet McGill, MD (1)  ·  Jay S. Skyler, M.D., M.A.C.P. (1)  ·  Katerina Simunkova, PhD (1)  ·  Manasi Jaiman, MD (1)  ·  Paolo Pozzilli, MD (1)  ·  Roy W Beck, M.D., Ph.D. (1)  ·  Sven M Carlsen, MD PhD (1)  ·  Sven M Carlsen, MD, PhD (1)

Results publications

PMID 23570538

NIH funding

2023 (1)